These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34428532)

  • 21. The ocular manifestations of atopic dermatitis and rosacea.
    Eiseman AS
    Curr Allergy Asthma Rep; 2006 Jul; 6(4):292-8. PubMed ID: 16822381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety considerations in topical treatments for atopic dermatitis.
    Nicol NH
    Pediatr Nurs; 2011; 37(6):295-301; quiz 302. PubMed ID: 22256690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reference for common contact allergens present in prescription topical corticosteroids.
    Mologousis M; Goldminz AM
    J Am Acad Dermatol; 2022 Feb; 86(2):476-478. PubMed ID: 34571060
    [No Abstract]   [Full Text] [Related]  

  • 24. Topical corticosteroid phobia among parents of children with atopic dermatitis in a semirural area of Norway.
    Gustavsen HE; Gjersvik P
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):168. PubMed ID: 25174954
    [No Abstract]   [Full Text] [Related]  

  • 25. A systematic review of topical corticosteroid withdrawal ("steroid addiction") in patients with atopic dermatitis and other dermatoses.
    Hajar T; Leshem YA; Hanifin JM; Nedorost ST; Lio PA; Paller AS; Block J; Simpson EL;
    J Am Acad Dermatol; 2015 Mar; 72(3):541-549.e2. PubMed ID: 25592622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.
    Beck LA; Thaçi D; Hamilton JD; Graham NM; Bieber T; Rocklin R; Ming JE; Ren H; Kao R; Simpson E; Ardeleanu M; Weinstein SP; Pirozzi G; Guttman-Yassky E; Suárez-Fariñas M; Hager MD; Stahl N; Yancopoulos GD; Radin AR
    N Engl J Med; 2014 Jul; 371(2):130-9. PubMed ID: 25006719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence.
    Kalavala M; Dohil MA
    Am J Clin Dermatol; 2011 Feb; 12(1):15-24. PubMed ID: 21067248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three types of cataract associated with atopic dermatitis and chronic topical corticosteroid use: A case report.
    Ruiz-Lozano RE; Hernandez-Camarena JC; Roman-Zamudio M; Alcazar-Félix RJ; Davila-Cavazos O; Cardenas-de la Garza JA
    Dermatol Ther; 2021 Jan; 34(1):e14600. PubMed ID: 33248006
    [No Abstract]   [Full Text] [Related]  

  • 29. Prescriptions for atopic dermatitis: oral corticosteroids remain commonplace.
    Alexander T; Maxim E; Cardwell LA; Chawla A; Feldman SR
    J Dermatolog Treat; 2018 May; 29(3):238-240. PubMed ID: 28789575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing the relationship between topical corticosteroid phobia and susceptibility to misinformation in patients with atopic dermatitis.
    Hrin ML; Bray JK; Fleischer AB; Feldman SR
    J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):e115-e118. PubMed ID: 34534378
    [No Abstract]   [Full Text] [Related]  

  • 31. Adrenal axis suppression caused by a small dose of a potent topical corticosteroid.
    Miyachi Y
    Arch Dermatol; 1982 Jul; 118(7):451-2. PubMed ID: 7092266
    [No Abstract]   [Full Text] [Related]  

  • 32. Desonide foam: a review.
    Parish D; Scheinfeld N
    Drugs Today (Barc); 2008 Jan; 44(1):55-62. PubMed ID: 18301804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low Risk of Adrenal Insufficiency After Use of Low- to Moderate-Potency Topical Corticosteroids for Children With Atopic Dermatitis.
    Davallow Ghajar L; Wood Heickman LK; Conaway M; Rogol AD
    Clin Pediatr (Phila); 2019 Apr; 58(4):406-412. PubMed ID: 30694073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical calcineurin inhibitors with topical corticosteroids for atopic dermatitis: A 15-year experience.
    Broeders JA; Ahmed Ali U; Fischer G
    J Am Acad Dermatol; 2016 Aug; 75(2):410-419.e3. PubMed ID: 27177441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Triderm in the treatment of atopic dermatitis].
    Kaliuzhnaia DD
    Voen Med Zh; 1999 Feb; 320(2):53-5. PubMed ID: 10330896
    [No Abstract]   [Full Text] [Related]  

  • 36. Atopic dermatitis in children in the United States, 1997-2004: visit trends, patient and provider characteristics, and prescribing patterns.
    Horii KA; Simon SD; Liu DY; Sharma V
    Pediatrics; 2007 Sep; 120(3):e527-34. PubMed ID: 17766497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The therapeutic activity of Cutivate in the treatment of inflammatory skin diseases].
    Trubin VP; Dubinin VP; Glad'ko OV; Volkova OA
    Voen Med Zh; 2000 Mar; 321(3):36-8. PubMed ID: 10815538
    [No Abstract]   [Full Text] [Related]  

  • 38. Optimizing pharmaceutical care for pediatric patients with dermatitis: perspectives of parents and pharmacy staff.
    Koster ES; Philbert D; Wagelaar KR; Galle S; Bouvy ML
    Int J Clin Pharm; 2019 Jun; 41(3):711-718. PubMed ID: 31020600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spotlight on topical pimecrolimus in pediatric atopic dermatitis.
    Yang LP; Curran MP
    Am J Clin Dermatol; 2010; 11(4):295-8. PubMed ID: 20509720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rebound vasodilation from long-term topical corticosteroid use.
    Rapaport M
    Arch Dermatol; 2007 Feb; 143(2):268-9. PubMed ID: 17310013
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.